Illumina Reports Preliminary Q4 Revenues of $260M | GenomeWeb

By a GenomeWeb staff reporter

This article has been updated from a previous version to include additional details from the company's presentation at the JP Morgan Healthcare Conference.

NEW YORK (GenomeWeb News) – Illumina on Tuesday announced preliminary fourth-quarter revenues of approximately $260 million and preliminary full-year 2010 revenue of approximately $901 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.